Genetic variants associated with warfarin dosage in Kuwaiti population
Affiliations
Affiliations
- Population Genomics & Genetic Epidemiology Unit, Dasman Diabetes Institute, P.O. Box 1180, Dasman, 15462, Kuwait.
- Functional Genomics Unit, Dasman Diabetes Institute, P.O. Box 1180, Dasman, 15462, Kuwait.
Abstract
Assessing the distinct prevalence or absence of genetic variants associated with differential response to the anticoagulant medication of warfarin in different population groups is actively pursued by pharmacogenomics community. Populations from Arabian Peninsula are underrepresented in such studies. By way of examining exome- and genome-wide genotype data from 1395 Arab individuals in Kuwait, we report distinct occurrence of warfarin response-related variants rs12460590_A/CYP2A7, rs2108622_T/CYP4F2, rs2884737_C/VKORC1 and distinct absence of rs11150606_C/PRSS53 in Kuwaiti population. The presented results in conjunction with similar literature reports on Qatari population enhance the worldwide understanding on population-specific distributions of genetic variants associated with warfarin drug dosage.
Keywords: Arab population; CYP2A7; CYP4F2; Kuwait; PRSS53; VKORC1; anticoagulation; exome; genetic variants; warfarin.
Similar articles
Cen HJ, Zeng WT, Leng XY, Huang M, Chen X, Li JL, Huang ZY, Bi HC, Wang XD, He YL, He F, Zhou RN, Zheng QS, Zhao LZ.Br J Clin Pharmacol. 2010 Aug;70(2):234-40. doi: 10.1111/j.1365-2125.2010.03698.x.PMID: 20653676 Free PMC article.
Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M, Yoshizawa M, Moriwaki H, Akimoto T, Tsuji D, Inoue K, Itoh K.Thromb Res. 2015 May;135(5):861-6. doi: 10.1016/j.thromres.2015.02.019. Epub 2015 Feb 27.PMID: 25747538
Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.
Singh O, Sandanaraj E, Subramanian K, Lee LH, Chowbay B.Drug Metab Pharmacokinet. 2011;26(2):130-6. doi: 10.2133/dmpk.dmpk-10-rg-080. Epub 2010 Nov 12.PMID: 21084764
Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB; Clinical Pharmacogenetics Implementation Consortium.Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7.PMID: 21900891 Free PMC article. Review.
Yang L, Ge W, Yu F, Zhu H.Thromb Res. 2010 Apr;125(4):e159-66. doi: 10.1016/j.thromres.2009.10.017. Epub 2009 Nov 25.PMID: 19942260 Review.
Cited by
The QChip1 knowledgebase and microarray for precision medicine in Qatar.
Rodriguez-Flores JL, Messai-Badji R, Robay A, Temanni R, Syed N, Markovic M, Al-Khayat E, Qafoud F, Nawaz Z, Badii R, Al-Sarraj Y, Mbarek H, Al-Muftah W, Alvi M, Rostami MR, Cruzado JCM, Mezey JG, Shakaki AA, Malek JA, Greenblatt MB, Fakhro KA, Machaca K, Al-Nabet A, Afifi N, Brooks A, Ismail SI, Althani A, Crystal RG.NPJ Genom Med. 2022 Jan 19;7(1):3. doi: 10.1038/s41525-021-00270-0.PMID: 35046417 Free PMC article.
VKORC1 variants as significant predictors of warfarin dose in Emiratis.
Al-Mahayri ZN, Al Jaibeji HS, Saab Y, Soliman K, Al-Gazali L, Patrinos GP, Ali BR.Pharmgenomics Pers Med. 2019 Apr 17;12:47-57. doi: 10.2147/PGPM.S187350. eCollection 2019.PMID: 31114289 Free PMC article.
Albassam A, Alshammari S, Ouda G, Koshy S, Awad A.PLoS One. 2018 Sep 5;13(9):e0203033. doi: 10.1371/journal.pone.0203033. eCollection 2018.PMID: 30183746 Free PMC article.
Allyn-Feuer A, Ade A, Luzum JA, Higgins GA, Athey BD.Pharmacogenomics. 2018 Apr;19(5):413-434. doi: 10.2217/pgs-2017-0186. Epub 2018 Feb 5.PMID: 29400612 Free PMC article.